Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis.
Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.
First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS.
Effect of Genzyme’s LEMTRADA™ maintained in patients beyond two-year pivotal MS studies
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Oral therapies for multiple sclerosis: a review of agents in phase III development or recently approved.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Memory rehabilitation for people with multiple sclerosis.
Opposing Effects of Membrane-Anchored CX3CL1 on Amyloid and Tau Pathologies via the p38 MAPK Pathway.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Chronic cerebrospinal venous insufficiency: masked multimodal imaging assessment.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Varicella-zoster virus acute myelitis in a patient with MS treated with natalizumab.
Diffuse and heterogeneous T2-hyperintense lesions in the splenium are characteristic of neuromyelitis optica.
Progressive Multifocal Leukoencephalopathy
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.
Magnetic resonance imaging in multiple sclerosis - patients' experiences, information interests and responses to an education programme.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial.
CHMP recommends granting a marketing authorization for Santhera's Raxone® for the treatment of Leber's Hereditary Optic Neuropathy (LHON)
Treatment selection and experience in multiple sclerosis: survey of neurologists.
Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.

Pages